AMA Journal of Ethics

One reason for neglect of women’s health as patients and subjects has been restrictions on uterine transfer of modified human embryos, a boundary that has now been crossed.

Facial transplantation must establish approaches to assessing QoL in candidates and recipients that use meaningful outcomes.

Global health outreach programs can risk benefitting students from resource-rich areas of the world more than the patients in resource-poor areas of the world. This month’s episode of Ethics Talk explores an alternative to academic health center-based health outreach programs.

Short-term experiences in global health are common ways trainees engage in global health activities. Professional societies take active roles in addressing these ethical challenges.

In 1984, Hatch-Waxman tried to balance drug innovation against availability; it was tested in the US Supreme Court in 2013.

How do we determine what a fair price for a life-saving prescription medication should be? This month, we discuss what is means for a price to be “fair” and explore the current legal and economic landscape of prescription drug pricing in the US.

When patients are unable to express their wishes and do not have surrogates or advance directives, which and whose values should inform decision making for them? We discuss ethical complexities of caring for unrepresented patients.

Safeguards are urgently needed for assessments of what constitutes appropriate care for unaccompanied minors in US detention facilities.

When a patient’s preference expresses injustice, how should clinicians respond? We discuss individual and organizational responses.

When evaluating a 10-year-old with leukemia and chemo-induced heart failure for VAD placement, a team considers what to do.